Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease.  Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates.  Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.

Biotechnology

Education

Avidity

Avidity's headquarters in San Diego, CA, United States

Sarah Boyce

Gavin Dawson

Scott Bernstein

Laura Genatossio

Erik Lemay

Mary Malito

Gail Sibert

Jason J.

Danielle Walters

Kelley Allison

Jennifer Rivera

Lisa Lejuwaan

Yoshi Inuzuka

Gulin Erdogan

Regi Reynoso

Jennifer Perkins

Michael Cochran

Seb Caille

Shah Hussain

Krista Letizia

Gautam Nayar

Tim Buck

Ze Cong

Qing Chang M.d.

Alissa Peters

Lynne Pratt

Eileen Blasi

Steve Hughes

Annie Vanselow

Zachary Richardson

Michael MacLean

Scott Hager

Arthur A. Levin

Charles Calderaro III

Carmen Castrillo-Viguera

Betania Glorio

Kat Lange

Mike Flanagan

Mike MacLean

Joseph Johnston

W. Michael Flanagan

Teresa McCarthy

Carsten Boess

Tamar Thompson

Eric Mosbrooker

Noreen Henig

Edward Kaye

Troy Wilson

The Scientific Research Team at Avidity Biosciences is dedicated to advancing the development of antibody-siRNA conjugates (ASC™). Comprising scientists specialized in toxicology, bioinformatics, drug discovery, and biomarkers, the team collaborates to design, synthesize, and validate innovative ASC therapies targeting disease-associated mRNAs. Their work involves rigorous experimentation, clinical evaluation, and the optimization of drug-like properties to advance precision medicine solutions for genetic diseases.

Scientific Research Team

This department oversees the planning, execution, and management of clinical studies and data analysis to ensure effective product development and market access.

Clinical Development and Operations

This department oversees all aspects of quality assurance and compliance to ensure products meet regulatory standards and internal guidelines.

Quality Assurance

The Accounting and Finance team at Avidity Biosciences manages the company's financial health by overseeing technical accounting, financial reporting, budgeting, and financial planning and analysis. They ensure compliance with financial regulations, prepare detailed financial statements, and provide strategic insights to support decision-making and drive business growth.

Accounting and Finance

The Clinical Operations Team at Avidity Biosciences manages the planning, execution, and oversight of clinical trials for ASC™ therapies. They ensure that clinical studies are conducted efficiently, ethically, and within regulatory guidelines, coordinating between various departments to collect, manage, and analyze clinical data. The team is also responsible for optimizing health economics and outcomes research to demonstrate the therapeutic value of ASC™ treatments.

Clinical Operations Team

This department manages and oversees regulatory compliance and strategic programs related to CMC (Chemistry, Manufacturing, and Controls) in the pharmaceutical industry.

CMC Regulatory Affairs

Avidity

Org chart

Board & advisors

Teams

Scientific Research Team

Clinical Development and Operations

Quality Assurance

Accounting and Finance

Clinical Operations Team

CMC Regulatory Affairs

Offices

Avidity

Org chart

Board & advisors

Teams

Scientific Research Team

Clinical Development and Operations

Quality Assurance

Accounting and Finance

Clinical Operations Team

CMC Regulatory Affairs

Offices

Related companies